Skip to main content
    S

    Senseonics Holdings, Inc. Common Stock (SENS)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $10.90
    +0.32 (+3.02%)

    Market Cap: $579.58M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Senseonics Holdings, Inc. Common Stock (SENS) Valuation Multiples

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Senseonics Holdings, Inc. Common Stock (SENS) trades at 11.9x sales and 9.2x book value. Its forward P/E is 21.0x.

    Current Multiples

    MultipleValue
    P/E (trailing)N/A
    Forward P/E21.0x
    Price to sales11.9x
    Price to book9.2x
    PEGN/A
    FCF yield-15.9%
    As of Nov 17, 2026

    Valuation History

    Over the 7 of the 10 year ends shown that have a P/S, its P/S ranged from 6.4x in 2025 to 754.2x in 2016. 2025 was the lowest of those years.

    Year endPriceP/SP/B
    2025$5.526.4x3.8x
    2024$10.4714.8xN/A
    2023$11.4013.9x8.4x
    2022$20.60N/AN/A
    2021$53.40N/AN/A
    2020$17.44N/AN/A
    2019$18.328.2xN/A
    2018$51.8022.0x6.4x
    2017$53.2051.9x50.2x
    2016$53.40754.2xN/A
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported.

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About SENS

    What is SENS's forward P/E ratio?

    Senseonics Holdings, Inc. Common Stock has a forward P/E ratio of 21.0x.

    Is SENS stock overvalued?

    GNG's valuation label for SENS is Fairly valued.

    What is SENS's price to sales ratio?

    Senseonics Holdings, Inc. Common Stock has a price to sales ratio of 11.9x.